Ilov Nikolay, Ilov Nikolay, Nechepurenko Anatoly, Abdulkadyrov Albert, Paskeev Damir, Damrina Elena, Kulikova Elena, Terent'eva Marina, Stompel Dinara, Tarasov Dmitry
Federal Center for Cardiovascular Surgery, Astrakhan, Russia. Presented in Venice Arrhythmias 2015, Venice, Italy.
J Atr Fibrillation. 2016 Jun 30;9(1):1391. doi: 10.4022/jafib.1391. eCollection 2016 Jun-Jul.
Pocket hematoma (PH) is a common complication of implantations of cardiac electrophysiological devices with occurring at a particularly high rate in patients on oral anticoagulation or antiplatelet treatment. Different pharmacological agents with hemostatic effect are used to avoid PH. We supposed that the vasoconstrictor effects of epinephrine may reduce bleeding extent and be effective in prevention of PH. Maitre is the first clinical trial conducted with an aim to show the safety and efficacy of epinephrine in PH prophylaxis. We randomized 133 patients to receive either epinephrine or saline solution, which were added to a local anesthetic administered during pacemaker implantation. In cases of diffuse bleeding a method of pocket drainage was effectively used. Results showed that risk of PH was significantly higher in the group receiving epinephrine. We conclude that a local epinephrine effect may lead to a false impression of adequate hemostasis and force a surgeon to refuse from drainage insertion.
囊袋血肿(PH)是心脏电生理设备植入术后的常见并发症,在接受口服抗凝或抗血小板治疗的患者中发生率尤其高。人们使用不同的具有止血作用的药物来避免发生PH。我们推测肾上腺素的血管收缩作用可能会减少出血程度,并有效预防PH。“Maitre”是首个旨在证明肾上腺素在预防PH方面的安全性和有效性的临床试验。我们将133例患者随机分为两组,分别接受肾上腺素或生理盐水,二者均添加到起搏器植入过程中使用的局部麻醉剂中。对于弥漫性出血的情况,有效地采用了囊袋引流方法。结果显示,接受肾上腺素治疗的组发生PH的风险显著更高。我们得出结论,局部使用肾上腺素的效果可能会导致对止血充分性产生错误印象,并迫使外科医生拒绝插入引流管。